Average Co-Inventor Count = 1.9

ph-index = 8

Forward Citations = 338(Granted Patents)

Location History:

Zürich, CH (2001 - 2002)
Zurich, CH (1986 - 2003)

Company Filing History:

Imperial Chemical Industries Limited

patents

3 out of 1,678

Degussa Aktiengesellschaft

Basf Aktiengesellschaft

patents

6. 1 out of 4,942

Hoffmann-la Roche Inc.

Years Active: 1986-2003

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6617425 - Peptides (2003-09-09),

2. 6441112 - TADDOL and titanium ( ) taddolate dendrimers and composition (2002-08-27),

3. 6255100 - Cyclosporin fermentation process (2001-07-03),

4. 6211316 - Taddol and titanium (IV) taddolate dendrimers (2001-04-03),

5. 6099751 - Chiral compounds (2000-08-08),

6. 6090913 - Transesterification and other conversion reactions of acid derivatives, (2000-07-18),

7. 5981479 - Cyclosporins (1999-11-09),

8. 5767069 - Cyclosporins (1998-06-16),

9. 5386035 - Method of producing optically active 1,3-imidazolidine-4-ones (1995-01-31),

10. 4983766 - Optically active B hydroxy acids (1991-01-08),

11. 4937359 - Process for preparing (S)-4-methyl-.beta.-butyrolactone (1990-06-26),

12. 4835294 - 2-Substituted-6-methyl-1,3-dioxan-4-one (1989-05-30),

13. 4812476 - Process for stereosectively preparing optically active compounds (1989-03-14),

14. 4771122 - Novel cyclosporins (1988-09-13),

15. 4745218 - Process for the enantioselective production of (1988-05-17),

Title: Dieter Seebach: Innovator in Peptide Chemistry

Introduction

Dieter Seebach is a prominent inventor based in Zurich, Switzerland. He has made significant contributions to the field of peptide chemistry, holding a total of 18 patents. His work has had a profound impact on various applications in polymer science and catalysis.

Latest Patents

Among his latest patents, Seebach has developed TADDOL and titanium taddolate dendrimers. These dendrimers are described for their use as crosslinkers in polymerization reactions. Additionally, the use of titanium salts of polymer-bound TADDOL dendrimers as catalysts in enantioselective addition reactions is disclosed in his patents.

Career Highlights

Throughout his career, Dieter Seebach has worked with notable companies such as Novartis AG and Imperial Chemical Industries Limited. His expertise in peptide chemistry has positioned him as a leader in his field, contributing to advancements in both academic and industrial settings.

Collaborations

Seebach has collaborated with esteemed colleagues, including Soo Young Ko and Hans Kobel. These partnerships have further enriched his research and innovation efforts.

Conclusion

Dieter Seebach's contributions to peptide chemistry and his innovative patents highlight his role as a key figure in the scientific community. His work continues to influence advancements in polymer science and catalysis.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.